CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Clinical trials for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Simple gloves may shield cancer patients from Chemo's painful side effect
Prevention OngoingThis study is testing if wearing two layers of surgical gloves during chemotherapy can prevent nerve pain, a common and debilitating side effect. It involves 104 breast cancer patients in South Korea who are receiving a specific chemo drug called paclitaxel. The goal is to see if…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Young-Joon Kang • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC
-
Can a natural supplement soothe Chemo's painful side effects?
Symptom relief OngoingThis study is testing if a dietary supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer survivors. About 88 participants who have had these symptoms for at least 3 months will take either PEA or a placebo pill for 8 weeks. Research…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Can exercise ease the lingering pain of chemotherapy?
Symptom relief OngoingThis study is testing whether a 10-week, home-based exercise program is practical, safe, and helpful for cancer survivors who have lasting nerve pain, numbness, or tingling from chemotherapy. Researchers will work with 40 participants to see if the program improves symptoms, stre…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New hope to stop Chemo's painful side effect
Symptom relief TerminatedThis trial is testing whether a substance called GM1 can prevent or reduce nerve damage (neuropathy) caused by paclitaxel chemotherapy. It involves about 98 people with metastatic breast cancer who are receiving this specific chemo. Participants are randomly assigned to receive e…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Needles vs. nerve pain: can acupuncture ease Chemo's harsh side effect?
Symptom relief OngoingThis study is testing if a form of acupuncture using mild electrical stimulation can help reduce pain from nerve damage caused by chemotherapy. It involves 255 cancer survivors who have finished treatment but still suffer from this painful side effect. Participants are randomly a…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Yoga vs. education vs. usual care: the fight against chemo pain
Symptom relief OngoingThis study is testing whether yoga can help reduce nerve pain caused by chemotherapy, a common side effect for cancer survivors. Researchers are comparing yoga classes to educational sessions and standard medical care to see which best improves pain, balance, and quality of life.…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
Can walking and light weights beat drugs for chemo pain?
Symptom relief OngoingThis study is testing if a simple, home-based exercise program can better relieve the nerve pain, numbness, and tingling that often follows chemotherapy. About 133 cancer patients who have this side effect are being assigned to either follow a 6-week walking and resistance progra…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated Mar 18, 2026 14:42 UTC